Denali Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| General Public | 417,494 | 0.29% |
| Individual Insiders | 6,659,986 | 4.63% |
| Public Companies | 7,155,243 | 4.97% |
| Institutions | 129,688,901 | 90.1% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.1%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 13,788,517 | R$2.1b | 4.66% | 0.01% | |||
| 13,345,887 | R$2.0b | -3.03% | 0.14% | |||
| 11,177,234 | R$1.7b | -1.2% | no data | |||
| 10,727,450 | R$1.6b | 9.2% | 0.04% | |||
| 7,909,114 | R$1.2b | 11% | 0.01% | |||
| 7,828,372 | R$1.2b | 3,260% | 0.01% | |||
| 7,155,243 | R$1.1b | -43.9% | no data | |||
| 5,355,832 | R$809.2m | -6.14% | 0.12% | |||
| 4,460,732 | R$674.0m | -6.3% | 5.96% | |||
| 4,252,011 | R$642.4m | -4.12% | no data | |||
| 3,890,889 | R$587.9m | 59.9% | 0.01% | |||
| 3,731,695 | R$563.8m | 0% | 0.82% | |||
| 3,047,264 | R$460.4m | 51% | 0.02% | |||
| 2,955,477 | R$446.5m | -0.91% | no data | |||
| 2,869,795 | R$433.6m | 27.2% | 0.01% | |||
| 2,241,211 | R$338.6m | 0% | no data | |||
| 2,111,441 | R$319.0m | 0% | no data | |||
| 2,000,000 | R$302.2m | 0% | 2.02% | |||
| 1,967,141 | R$297.2m | -18.7% | 0.07% | |||
| 1,559,442 | R$235.6m | 10% | 0.01% | |||
| 1,531,032 | R$231.3m | 48.5% | no data | |||
| 1,519,295 | R$229.5m | 0% | 0.04% | |||
| 1,315,502 | R$198.8m | -13.8% | 0.01% | |||
| 1,238,499 | R$187.1m | 13.8% | 0.01% | |||
| 1,091,018 | R$164.8m | -4.42% | 0.02% |